Ethics in New Medicine: Tissue Transplants by Moore, Francis D.
Ethics in New Medicine: Tissue Transplants* 
FRANCIS D. MOORE 
Harvard Medical School, Boston, Massachusetts 
Conservatism in medicine is a pos-
ture of comfort. The physician who 
lets a patient go his way with little 
more than a squeeze of the hand, 
a pain pill, or a knowing look to the 
relatives, can console himself that it 
has been this way before. It is also 
the easiest way. Then when another 
physician comes along to state that a 
certain disease can indeed be removed, 
but by a new and difficult procedure 
after careful study by new biochemical 
discriminants, the conservative is dis-
turbed. He sees his authority chal-
lenged. He feels a deep uneasiness 
that many of his ways may soon be-
come outmoded, particularly if he is 
inexperienced in, or unable to under-
stand or perform, the new procedure. 
He becomes outraged when he dis-
covers that several of the new opera-
tions have resulted in fatality rather 
than cure. Therefore, with the strong 
conviction that he is protecting the 
welfare of his patient, he claims that 
this new departure is still only experi-
mental , and therefore unethical. 
Postgraduate education in medicine 
is devoted to surmounting this innate 
conservatism. It is a tribute to the 
medical profession that each year 
thousands of doctors return to sources 
of learning to refresh their sense of the 
"tried," if not always the "true" in 
the sense of widely proven. Practition-
ers who return periodically to hos-
pitals, where challenge of the old is a 
way of life, find that they overcome 
this human tendency to entrench, crys-
tallize and defend an unchanging art. 
* This paper originally appeared in The 
Nation (200: 358-362 'April 5', 1965). It 
is reprinted here with the kind permission 
of the publisher. 
Nevertheless, the history of such 
positions against advance, positions 
taken on the ground of ethics, is long 
and illustrious. It ranges all the way 
from the use of ether in childbirth to 
the use of aseptic techniques in the 
operating room, from the prevention 
of puerperal sepsis by isolation to 
the removal of brain tumors, and fin-
ally includes even the repair of valvu-
lar diseases of the heart! An older and 
more conservative generation has each 
time looked askance at these new 
ideas and new procedures and, at 
some point in heated controversy, has 
declared them unethical. 
And yet, some are! Some "inno-
vations" are indeed quite unethical 
and unacceptable! How should we 
consider the transplantation of goat 
glands to restore the waning virility 
of the elderly male? Or the treatment 
of arthritis by irradiation from outer 
space? Or the administration of small 
doses of creatinine diluted in water, 
to raise the hopes of cancer patients 
... at a price? 
How can the lay person, the legis-
lator or the newspaper writer steer 
his way through such controversy? 
What values provide guideposts, what 
criteria are standards for acceptability 
in medical innovation? How is one to 
regard the newest entry in this field, an 
entirely new kind of surgery: the trans-
plantation of organs from one person 
to another? 
As new fields of clinical science 
emerge, they come under fire from 
many directions. The commonest criti-
cism is that new procedures are ex-
perimental and therefore their em-
ployment in the care of patients is 
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immoral. It accomplishes little to point 
out that all of medicine is in a sense 
experimental, and that most of the 
daily tasks in practice-large or small 
-are in a very real sense tentative, 
insecure. No one can ever take for 
granted his mastery over nature. One 
must always approach his conquest of 
natural forces with a high sense of risk, 
of uncertainty and of experiment. One 
must seek the same clever skill em-
ployed by the glider pilot who rides 
air currents that at one moment sup-
port him upward , and the next-if 
miscalculated-dash him against the 
hillside. This simple idea, that applied 
human biology involves the hazard of 
repeated experiment, applies to all of 
medicine and surgery. A few examples 
will suffice. 
A surgical operation employs bac-
teriology in just this way. An open 
incision bares large areas of sterile 
human tissue to the invasive bacteria 
of the surrounding world. Cutting, 
sewing, dissecting the tissue, an opera-
tion becomes an experiment employ-
ing techniques of bacteriology to avoid 
bacterial infection. If performed prop-
erly, the tissues will heal without in-
fection; if faults and breaks occur, 
there is infection. Soon after Pasteur 
and Lister showed the bacterial nature 
of infection, it became obvious that 
"every surgical operation is an ex-
periment in bacteriology." 
When a physician gives his patient 
digitalis for the first time, he is carry-
ing out an experiment in pharmacol-
ogy. If he has misjudged the dose be-
cause of some unforeseen abnormality 
in his patient, he must readjust his 
prescription on the basis of the elec-
trocardiogram and the heartbeat, work-
ing just as carefully as the scientist 
who manipulates a highly controlled 
system of variables in the laboratory. 
Even such a commonplace operation 
as exploratory laparotomy for acute 
appendicitis, undertaken as an emer-
gency in the midnight hours, harbors 
an element of experiment. "We are 
not sure what's the matter with Johnny, 
but we better have a look. If it is acute 
appendicitis, we can remove the ap-
pendix; if it is not, we are running 
little risk." 
Each patient and each patient's 
20 
disease is different from the last or 
the next. Each necessitates a rigorous 
approach to the phenomena of nature, 
of humanity and of illness. These in 
themselves are reasons enough for the 
continuing emphasis on biological sci-
ence in medical education. 
When we turn from these every-
day uncertainties of medicine and 
surgery to the more troublesome as-
pects of entirely new treatments for 
critical illness, we pass from smooth 
sailing into choppy waters. The same 
experimental aspects are there, but 
now uncertainty is accentuated. The 
doctor can no longer tell his patient the 
chances of success or failure because 
he does not know them himself-nor 
can he minimize the risk. 
At the present time, the patient 
dying of kidney failure has but two 
things to look forward to, other than 
a lingering and unpleasant death. One 
is a program of repeated dialyses or 
"blood washings" (on the artificial 
kidney) at high cost, bringing no possi-
bility of release from the shackles of re-
peated procedures, sensations of waste 
accumulation, and reattachment to the 
machine. The artificial kidney has 
brought new hope to many patients 
with short-term kidney disease capable 
of healing and recovery. But for highly 
destructive kidney diseases, such as 
chronic glomerulonephritis, chronic 
pyelonephritis and chronic polycystic 
disease, these repeated dialyses are but 
a series of temporary makeshifts-a 
way of staying alive but hardly a way 
of life. 
The other choice is to have a kidney 
transplantation. This carries many un-
certainties and several risks, both at 
the operation and later on, as well as 
hazards for the donor if a living donor 
is used. But despite these factors , kid-
ney transplantation has reached the 
point where many patients are now 
alive and well, up and about, and at 
home and at work, free of repeated 
dialyses, but still on medication, with 
their transplants working well. To ar-
rive at its present station, however 
insecure, this work has taken fifty 
years of gradual evolution and fifteen 
years of intensive research in America 
and Europe. 
The first long-term survival after 
homotransplant of a kidney (a homo-
transplant is a transplant between 
nontwin members of the same species) 
was in the spring of 1962, eight years 
after the first identical-twin transplan-
tation. Up to the autumn of 1964, al-
most 500 kidney transplantations had 
been carried out in this country and 
abroad, involving many different re-
lationships between donor and recipi-
ent. Of these, the large majority have 
been done since March, 1963; for 
these, no one can possibly claim "long-
term survivors!" It is now, as this 
procedure is gradually emerging from 
a small and tightly controlled research 
study to more widespread use, that the 
ethical question is being raised: is it 
ethical to offer a kidney transplant to 
a patient dying of kidney failure? 
"Good science is ethical science." 
Applied human biology finds meaning 
only in assistance for human suffering. 
In viewing any new therapy as an 
experiment in human biology, it is 
possible to draw up certain guidelines 
that will support its ethical and moral 
climate. These guidelines are much the 
same for any medical advance or clin-
ical research, but for each there are 
special problems and details to be 
served to meet the humane standards 
that all must seek. 
The first guideline requires that the 
patient and his family be brought to 
an understanding of the alternatives 
through conversation and education. It 
is asking too much of a suffering pa-
tient to expect from him a final de-
cision; he has neither the dispassionate 
view nor the background in biology 
required for such a decision. Yet he 
must be enabled to understand what 
lies ahead, what the possibilities are, 
and to enter the procedure of his own 
free will and clear assent. Even more 
important, this gives him a positive 
motivation to aid and assist his doctors. 
It is never possible to impose good 
surgical care on the unwilling; there is 
tangible gain in the confidence and 
cooperation that comes from education 
and understanding. 
This education will tell the patient 
and his family what a transplant really 
is, how it is done, how it is sutured in 
place, the meaning of urine output, 
the use of immuno-suppressive drugs 
and many other details. He should 
understand the risks, the question of 
timing, the utility of repeated dialyses, 
the various donor possibilities and the 
experience of the hospital group. Any 
patient with a good background in 
high school biology soon comes to 
understand a remarkable amount about 
any new medical procedure. 
The newest operation needs the 
most ancient clinical judgment for 
its success; the second guideline is, 
therefore, that each patient must re-
ceive the best and most experienced 
medical care available. No operation 
or medical procedure can stand alone. 
It succeeds only with the assistance of 
all the rest of modern medicine and 
surgery, the help of many doctors, 
nurses, blood bankers, laboratory tech-
nicians, and the participation of that 
whole constellation of human activities 
encompassed in the modern hospital. 
While an isolated research institute 
may contribute much to the idea, its 
most effective implementation is in 
the skilled environment of a busy hos-
pital service. Consultation among doc-
tors provides the checks and balances 
that avoid excess of one view, or a one-
sided bias in interpretation. When four 
or five keenly interested persons are 
concerned with the patient's care, un-
der the guidance of one of their num-
ber, there is a healthy openness of 
view that exemplifies the freedom of 
communication and sharing of knowl-
edge so essential to the care of complex 
illness. 
Work on man must be the culmina-
tion of an effort, not its initiation; the 
third guideline is that preliminary 
study in the laboratory by the doctors 
doing the work (not someone else!) 
must yield enough skill in performance 
and likelihood of success to justify 
the attempt. The so-called "great ad-
vances" of modern medicine, no mat-
ter what their nature, have had a sound 
basis in laboratory work before they 
were moved to the clinic. This basic 
laboratory groundwork makes their 
clinical application not a mere adven-
ture, but the establishment of a new 
routine. When this important guideline 
has been neglected, with an attempt to 
make the "great leap" straight from 
the test tube to the patient, tragedy 
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has resulted. The one example in the 
transplant field wherein the boundaries 
of ethical acceptance appear to have 
been crossed shows up at this point. 
The initial transplantation from chim-
panzee to man was well based in 
laboratory work on blood grouping; 
but the subsequent series of attempts 
to place baboon kidneys (and even 
other organs, some of them obviously 
too small to do the job) in man, rep-
resented a premature step based on 
inadequate laboratory work. It is quite 
possible to set up experimental inter-
primate heterografts (such as monkey 
to baboon, or monkey to anthropoid 
apes) which could have tested this 
fundamental hypothesis that immuno-
genetic acceptance might somehow be 
achieved more readily than with homo-
grafts. 
The exact locus of the laboratory in 
any advance of applied human biology 
depends on the nature of the work to 
be done. No dogma is effective for all. 
In cancer chemotherapy, for example, 
the only available animal model is the 
small laboratory rodent-rat or mouse. 
Spontaneous or transplantable tumors 
in larger vertebrates (permitting study 
and care resembling that in man) are 
but rarely available. In other fields, 
such as active immunization against 
poliomyelitis or measles, the final step 
somehow has to be made, and it is still 
a big one. It involves considerable h az-
ard even though the circumstances are 
less spectacular than a surgical opera-
tion. The initial test with vaccines is 
made cautiously and with small doses. 
It should never be done on captive or 
primitive populations who cannot un-
derstand the risk. 
In transplantation research this long 
step from test tube to man was taken 
only after a decade with the dog. The 
size of the dog, the size of his blood 
vessels, the ease of his care, the fre-
quency with which blood and urine 
tests can be made, and the ability to 
judge fine gradations in his clinical 
status by physical appearance alone, 
have all made study in the dog basic 
not only to the science but also to the 
ethics of transplantation in man. Anti-
vivisectionists please take note: there 
could be nothing more shocking than 
moving straight from the rat to man 
with the transplantation of organs! 
And finally, as a fourth guideline of 
the utmost importance, each patient's 
case must be studied, documented as 
carefully as possible, and made availa-
ble to the general view. The study and 
documentation of each case must be 
so complete and accurate that any 
interested person can come to the 
hospital and spend a few days or weeks 
reviewing and challenging the proce-
dure or the data-and learning from 
them. There can be no toleration of 
secrecy. Every compound used, every 
procedure employed, must be fully 
known and made clear. When the 
time comes, the collected experience 
must be published with everything dis-
played, results both good and bad, so 
that the openness of modern science 
can be satisfied. There have been no 
breaches of this faith in the transplant 
field. Several transplant centers have 
now banded together to place data on 
computers for complete analysis. Any 
doctor in the world may join this 
project, so that his statistics, his 
failures and his successes are freely 
made available for all to see. 
But helpful as these guidelines are, 
no one of them fully answers the 
question unique to transplantation-
what about the donor? For the first 
time in the history of medicine a per-
fectly normal, healthy person has now 
been subjected to the rigors of a major 
surgical procedure and the removal of 
an organ, to help another. 
The principle of injury to one so as 
to help another is common throughout 
nature and is basic to the Christian 
ethic. Examples are not to be found in 
the protection of its young by hazard 
to the mother, or when one person has 
sacrificed himself to help another, in 
war or peace. But in these natural 
phenomena and altruistic events, there 
has never been a third party-the 
physician-advising the individual to 
take this risk. It has been an emotional 
rather than an intellectual decision, 
and a matter of personal choice. 
Medical science began to invade 
this field about 1915, with the develop-
ment of blood donation for transfu-
sion. Here the injury appeared to be 
minor and the body had methods to 
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compensate. The hazard in blood do-
nation lies not in any threat to the 
donor but in the threat to the recipient 
by the transmission of disease. 
The initial step in organ transfer was 
taken in 1954, with the first of the 
identical-twin transplants. Up to Sep-
tember, 1963, thirty-three identical-
twin transplants have been carried out 
in the world, of which twenty-two are 
still alive with kidneys functioning 
well. The success of identical-twin 
transplantation has become sufficiently 
assured so that it scarcely arouses a 
question of morality with regard to 
the recipient-who is dying from ter-
minal kidney disease. But as it bears 
on the donor, the ethical problem is as 
pressing and urgent now as it ever 
was, and is just as severe for the 
identical-twin donor as it is for the 
unrelated person, or for the father, 
mother or brother who seeks to be a 
kidney donor. 
There is no simple unitary ethical 
solution for kidney donation from a 
living person today. Nephrectomy (re-
moval of a kidney) carries a risk and a 
mortality. When enough have been 
done, it will be found that one has re-
sulted in fatality. When enough have 
been done, it will likewise be found 
that a subsequent injury to the opposite 
kidney has resulted in significant loss 
of function, shortening life. The like-
lihood of a donor's losing the use of 
his remaining kidney is very small, and 
has been estimated as being in the same 
range as an automobile fatality, yet 
probabilities and statistics are inescap-
able. Such a major procedure as ne-
phrectomy will surely exact its price 
when finally enough have been done. 
It is clear that the first priority in 
donor development lies in better 
methods for preserving kidneys from 
recently deceased persons-a situation 
that completely side-steps the use of 
the living donor. This is still a research 
problem (though many cadaver kid-
neys have functioned well), but it is a 
research problem with an ethical over-
tone. Until cadaver kidneys can be 
used for all, the living donor (closely 
related to the recipient) still yields the 
best chance for success. Some impor-
tant principles appear to be as follows: 
First, every effort should be made 
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to assure the maximum donor-recipient 
tissue compatibility. Despite advances 
in this area during the past year or two, 
the most reliable criterion is still that 
of close family relationship. 
Second, one must be assured that 
both kidneys of the donor are quite 
normal, that there is no disease of the 
upper or lower urinary tract, and that 
kidney donation will involve only the 
risk of nephrectomy itself. 
Third, the donor, just as the re-
cipient, must understand the risks, the 
alternatives, the hazards, the discom-
forts, and most especially the uncer-
tainties in the enterprise. If the donor 
is an identical twin, the prospects for 
success can be described with reasona-
ble optimism. If any other relationship, 
then the prospects in all their uncer-
tainty must be outlined clearly. 
But surely the most important thing, 
as mentioned above, is to move away 
from the living donor entirely. This 
requires intensive study of cadaver 
organ procurement, and the definition 
of those factors in the recently de-
ceased that bias the health of the 
remaining tissues. When the brain and 
heart are dead, then the patient is 
said to be "dead," even though many 
of his tissues are still alive, respiring 
in a blood stream increasingly devoid 
of oxygen, accumulating acid, but still 
alive for a few more minutes and sal-
vageable for life in a new host. The 
care of the dying patient must never 
be compromised by impending tissue 
donation. The finest tissue bank in 
the world is the body of a person 
recently deceased from causes not 
damaging the health of transplantable 
tissues. Death from certain types of 
injuries, heart disease or brain tumors 
has provided many useful tissues. If 
cancer, infection, chronic vascular dis-
ease or just plain old age enter the 
picture, then the organs are of little 
use or actually dangerous to another. 
Herein lies a whole new field of en-
deavor in which we, as doctors, need 
the help of lawyers and legislators to 
give us legal guidelines to steer us 
through the uncertainties. 
It is ironical to find that while tissue 
transplantation itself is being called 
into ethical question, in point of fact 
it is giving an entirely new meaning to 
human generosity as living persons or 
families of those recently dead make 
free donations of tissue for the assist-
ance of others. The ethical lesson of 
kidney transplantation may turn out 
to be on the side of the Good Samari-
tan rather than the Evil Scientist! 
It is a curious fact that although the 
general questions of ethics are not 
appropriate for examination by the 
methods of science, nonetheless a 
strong ethical flavor runs through all 
of science-"good science is ethical 
science." What are these features 
within science which give it ethical 
stature? 
"Experiment is perilous and decision 
difficult." In that well-worn phrase, 
"perilous" and "difficult" indicate two 
of the ethical values in scientific experi-
ment: courage and persistence. Other 
values have to do with rigorous per-
sonal honesty in viewing and display-
ing the results of scientific research, 
without prejudice, with a dispassionate 
discrimination, and with the selfdisci-
pline required to make a judgement 
valid. Those who enjoy the privilege 
of science must spend many years ac-
quiring an education so as to make 
their work meaningful. Ethical values 
in science include also such things as 
openness of communication, exchange 
of information, avoidance of secrecy, 
willingness to educate the young and 
the avoidance of selfish gain. 
Every few years the public is af-
fronted by some spectacular example 
wherein a self-styled scientist has 
kicked over these traces, and sought 
a quick victory over nature by diso-
beying these inner ethics of science. 
But science is a stern taskmaster; trans-
gressors are brought to a bitter judg-
ment. 
Examples are to be found in those 
goat-gland transplants. Though hardly 
science in any term, they were most 
assuredly devoid of the ethical content 
of careful study, openness of method, 
documentation, and analysis of results. 
The Nuremberg trials showed us 
another failure of ethics in experimen-
tation. When a so-called "scientific 
experiment" was conducted wholly at 
the expense of the welfare of human 
beings, nothing good came of it. Even 
the experimenter himself was finally 
debased and prostituted. 
Most recently in the public press 
there has been described a flagrant ex-
ample, where in science has shown that 
its own inner ethic must indeed be 
obeyed and respected. A person of 
previous scientific achievement has 
evidently tried to convince the public 
of the effectiveness in cancer treatment 
of a compound the identity of which 
he kept a secret-and indeed it truly 
was a secret, because as it now turns 
out, he himself did not know what it 
was! Instead of education and open-
ness, careful trial, clear publication, 
controlled results, documentation of 
good and bad clearly shown for all to 
see, advocacy here was on the basis of 
hearsay about a secret and unknown 
compound, based on testimonials from 
random patients. A travesty on all the 
guidelines we have discussed! And 
then, with a fitting irony, downfall 
came through the study of a scientist 
working in the laboratory and obeying 
the basic ethic of honesty and rigorous 
examination. While examining this 
highly publicized "cancer cure" by 
infrared spectroscopy, he found it to 
be creatine-a commonplace material 
present in large amounts in the bodies 
of all cancer patients. 
The study of patients is always more 
difficult and complicated than the study 
of controlled experiments in the labo-
ratory. Sick people can be difficult, de-
manding, biased and fickle; controls 
are hard to conceive and devise. The 
patient's own emotional involvement 
and that of the doctor himself often 
provide false evidences of success. 
Persons working in clinical research 
(research in patient care) are as much 
in need of special education for this 
complex work as is the physiologist 
working under highly controlled con-
ditions in the quiet of his laboratory. 
Five years ago, the field of tissue 
transplantation was in a very difficult 
phase of clinical research. Then came 
the demonstration of immunosup-
pressive pharmacology by scientists 
working with the New Zealand white 
rabbit. There was then a period of ad-
vance clear for all to see as studies in 
the dog confirmed their findings and 
were moved to man. But now again the 
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field of tissue transplantation has been 
advancing more slowly, awaiting its 
next stepwise upward progression. As 
this is written, several new modifica-
tions are coming along, any one of 
which might make tissue transplanta-
tion sa:er and more effective. Until 
then, the toilers in this vineyard must 
work with the methods they have, re-
specting some such guidelines as these, 
for ethics in the pursuit of veritas. 
It is most appropriate to raise 
ethical questions at a time like this, 
not only to strengthen and shore up 
the procedures of each group working 
in the field of transplantation but also 
to challenge the critic and put him 
on his mettle to show cause why this 
particular advance of medical science 
should be any more suspect than 
another. The laboratory scientist tends 
to be critical of the clinician, the 
physician of the surgeon; these petty 
chauvinistic antagonisms should never 
cloud the real issues of ethics and 
acceptability in applied human biology. 
Tissue transplantation, like other ad-
vances of the past, will react to the 
welfare of mankind if explored and 
exploited within the ethical bounds of 
science itself. Honesty and self-disci-
pline must be held as values of the 
same importance as the very essence 
of all medical ethics: the welfare of 
the patient. 
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